Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CDK9 as modifier of the IGF pathway and methods of use

CDK9 as modifier of the IGF pathway and methods of use

US Patent 8758994 · Granted Jun 24, 2014

Estimated economic value: $9,110,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof2023
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof2020
Fatty acid synthase inhibitor for use in the treatment of drug resistant cancer2019
Heterocyclic modulators of lipid synthesis and combinations thereof2019
Heterocyclic modulators of lipid synthesis2019
Heterocyclic modulators of lipid synthesis for use against cancer and viral infe2018
SCDs as modifiers of the p53 pathway and methods of use2014
EEF2K as modifiers of the PTEN/AKT pathway and methods of use2014
PLKS as modifiers of the beta catenin pathway and methods of use2014
PLKS as modifiers of the beta catenin pathway and methods of use2014
PIK4CA as modifier of the Rac pathway and methods of use2013
PIK4CA as modifier of the Rac pathway and methods of use2013